These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1858340)

  • 1. [Production of a fibrinogen concentrate from small amounts of human autologous blood plasma and its short-term characteristics].
    Veremeenko KN; Varetskaia TV; Kizim AI; Svital'skaia LA
    Vopr Med Khim; 1991; 37(1):44-6. PubMed ID: 1858340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of autologous fibrinogen adhesive.
    Weisman RA; Torsiglieri AJ; Schreiber AD; Epstein GH
    Laryngoscope; 1987 Oct; 97(10):1186-90. PubMed ID: 2443781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation o human fibrinogen of high purity and in high yield using polyethylene glycol 1000.
    Masri MA; Masri SA; Boyd ND
    Thromb Haemost; 1983 Apr; 49(2):116-9. PubMed ID: 6868007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin glue from single-donation autologous plasmapheresis.
    Casali B; Rodeghiero F; Tosetto A; Palmieri B; Immovilli R; Ghedini C; Rivasi P
    Transfusion; 1992 Sep; 32(7):641-3. PubMed ID: 1355621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preparation of fibrinogen concentrate for use as fibrin glue by four different methods.
    DePalma L; Criss VR; Luban NL
    Transfusion; 1993 Sep; 33(9):717-20. PubMed ID: 8212116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of human plasma fibrin stabilizing factor (factor XIII) from fibrinogen by fibrinogen polymer formation.
    Becker CM
    Biochem Biophys Res Commun; 1986 Jan; 134(2):678-84. PubMed ID: 3947344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid method for isolation of fibrinogen from human plasma by precipitation with polyethylene glycol 6,000.
    Vila V; Regañón E; Llopis F; Aznar J
    Thromb Res; 1985 Sep; 39(5):651-6. PubMed ID: 3936222
    [No Abstract]   [Full Text] [Related]  

  • 8. A simple technique for purification of fibrinogen from plasma by affinity chromatography on ristocetin-agarose.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jun; 18(5):707-15. PubMed ID: 7414556
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification of rat fibrinogen and its constituent chains.
    Van Ruijven-Vermeer IA; Nieuwenhuizen W
    Biochem J; 1978 Mar; 169(3):653-8. PubMed ID: 417720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human fibrinogen free of factor XIII: the pursuit of biological zero.
    Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():149-54. PubMed ID: 4629549
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of human fibrinogen and its derivatives by affinity chromatography on Gly-Pro-Arg-Pro-Lys-Fractogel.
    Kuyas C; Haeberli A; Walder P; Straub PW
    Thromb Haemost; 1990 Jun; 63(3):439-44. PubMed ID: 2402747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and immunochemical characterization of human plasma factor XIII.
    Kazama M; McDonagh J; Wagner RH; Langdell RD; McDonagh RP
    Haemostasis; 1976; 5(6):329-40. PubMed ID: 828130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-based tissue engineering: comparison of different methods of autologous fibrinogen isolation.
    Dietrich M; Heselhaus J; Wozniak J; Weinandy S; Mela P; Tschoeke B; Schmitz-Rode T; Jockenhoevel S
    Tissue Eng Part C Methods; 2013 Mar; 19(3):216-26. PubMed ID: 22889109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin sealant produced by the CryoSeal FS System: product chemistry, material properties and possible preparation in the autologous preoperative setting.
    Buchta C; Dettke M; Funovics PT; Höcker P; Knöbl P; Macher M; Quehenberger P; Treitl C; Worel N
    Vox Sang; 2004 May; 86(4):257-62. PubMed ID: 15144531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers--a thiol enhanced process.
    Procyk R; Adamson L; Block M; Blombäck B
    Thromb Res; 1985 Dec; 40(6):833-52. PubMed ID: 2868545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin.
    Procyk R; Blomback B
    Biochim Biophys Acta; 1988 Nov; 967(2):304-13. PubMed ID: 2903773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method of purifying fibrinogen with both biological and immunological activity from human plasma.
    Okuda M; Uemura Y; Tatsumi N
    Prep Biochem Biotechnol; 2003 Nov; 33(4):239-52. PubMed ID: 14606683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.
    Schmidt DE; Halmin M; Wikman A; Östlund A; Ågren A
    Scand J Clin Lab Invest; 2017 Oct; 77(6):397-405. PubMed ID: 28632435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.